Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...

Cancer is definitely preventable. Especially knowing the signs of cancer, participating in regular screening and being aware of the signs and symptoms of cancer can definitely help prevent ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...

INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...

A CRISPR-based system that erases itself from fly populations may offer a safer approach to tackling insecticide resistance ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Meet the jumbo phage. Scientists believe they’ve cracked the code on how its ‘secret handshakes’ act as a shield against the ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...